benefits of glp-1 tirzepatide Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role | Cardiovascular Diabetology 💉 Semaglutide vs. Tirzepatide —

Diabetes Care (1994) 17(8):9013.10.2337/diacare.17.8.901 55 MeierJJRosenstockJHincelin-MeryARoy-DuvalCDelfolieACoesterHVet alContrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: a randomized, open-label trial

Tirzepatide activates two hormone pathways simultaneouslyGLP-1 and GIP receptorswhich creates powerful appetite suppression but also carries a risk profile that includes headache reports in clinical trial data

I once weighed over 200 pounds

J Immunol Methods 358(12):18